Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Cardiology Reviews
  4. Volume 21, Issue 1
  5. Article
Volume 21, Issue 1
  • ISSN: 1573-403X
  • E-ISSN: 1875-6557

Abstract

Introduction

Infective Endocarditis (IE) has emerged to be one of the most impactful adverse complications post-transcatheter procedures, especially Transcatheter Pulmonary Valve Replacement (TPVR). We conducted a systematic review and meta-analysis with the aim of identifying the incidence of IE post-TPVR with the MELODY valve in the pediatric population.

Methods

A comprehensive literature search was performed across several prominent databases, including PubMed/MEDLINE, SCOPUS, and Science Direct. Studies compared the clinical outcomes of pediatric patients who received TPVR using the MELODY valve. Data extraction was done for variables like the total pediatric patient population that underwent TPVR with MELODY valve, mean age, the sex of the patients, the incidence rate of IE following the procedure, and the duration between the procedure and the occurrence of IE. Inverse Variance was used to estimate the incidence of IE in patients who underwent TPVR with respective 95% confidence interval (CI).

Results

In total, 4 studies with 414 pediatric patients who underwent TPVR using the MELODY valve were included in the study. The mean age of the study population was 12.7 ± 3.11 years. The pooled incidence of IE following TPVR with MELODY valve in the pediatric population was 17.70% (95% Cl 3.84-31.55; 0.00001). Additionally, the mean length of duration to develop IE following TPVR with MELODY valve in the pediatric population was 2.18 years (95% Cl 0.35-4.01; 0.00001).

Conclusion

Our meta-analysis reveals that IE post-TPVR with MELODY valve in pediatric patients is a significant complication, clinically and statistically. Further research needs to be done to understand the risk factors and develop better management strategies.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/ccr/10.2174/011573403X324878240903045701
2024-09-16
2025-05-25

  • From This Site

    /content/journals/ccr/10.2174/011573403X324878240903045701
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Stefanescu SchmidtA.C. ArmstrongA.K. AboulhosnJ.A. Transcatheter pulmonary valve replacement with balloon-expandable valves.JACC Cardiovasc. Interv.202417223124410.1016/j.jcin.2023.10.065 38267137
     [Google Scholar]
  2. BarfussS.B. SamayoaJ.C. EtheridgeS.P. Ventricular arrhythmias following balloon‐expandable transcatheter pulmonary valve replacement in the native right ventricular outflow tract.Catheter. Cardiovasc. Interv.20231012379387Epub ahead of print10.1002/ccd.30560 36709486
     [Google Scholar]
  3. LindsayI. AboulhosnJ. SalemM. LeviD. Aortic root compression during transcatheter pulmonary valve replacement.Catheter. Cardiovasc. Interv.201688581482110.1002/ccd.26547 27121036
     [Google Scholar]
  4. MartinM.H. ShahanavazS. PengL.F. Percutaneous transcatheter pulmonary valve replacement in children weighing less than 20 kg.Catheter. Cardiovasc. Interv.201891348549410.1002/ccd.27432 29193671
     [Google Scholar]
  5. McElhinneyD.B. SondergaardL. ArmstrongA.K. Endocarditis after transcatheter pulmonary valve replacement.J. Am. Coll. Cardiol.201872222717272810.1016/j.jacc.2018.09.039 30497557
     [Google Scholar]
  6. McElhinneyD.B. Prevention and management of endocarditis after transcatheter pulmonary valve replacement: Current status and future prospects.Expert Rev. Med. Devices2021181233010.1080/17434440.2021.1857728 33246368
     [Google Scholar]
  7. McElhinneyD.B. ZhangY. AboulhosnJ.A. Multicenter study of endocarditis after transcatheter pulmonary valve replacement.J. Am. Coll. Cardiol.202178657558910.1016/j.jacc.2021.05.044 34353535
     [Google Scholar]
  8. PageM.J. McKenzieJ.E. BossuytP.M. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews.BMJ202137210.1136/bmj.n71
     [Google Scholar]
  9. HaddawayN.R. PageM.J. PritchardC.C. McGuinnessL.A. PRISMA2020: An R package and Shiny app for producing PRISMA 2020-compliant flow diagrams, with interactivity for optimised digital transparency and open synthesis.Campbell Syst. Rev.2022182e123010.1002/cl2.1230
     [Google Scholar]
  10. ArmstrongA.K. BergerF. JonesT.K. Association between patient age at implant and outcomes after transcatheter pulmonary valve replacement in the multicenter Melody valve trials.Catheter. Cardiovasc. Interv.201994460761710.1002/ccd.28454 31419019
     [Google Scholar]
  11. Solana-GraciaR. RuedaF. BetriánP. Pediatrics spanish registry of percutaneous melody pulmonary valve implantation in patients younger than 18 years.Rev. Esp. Cardiol.201871428329010.1016/j.rec.2017.07.013 29042164
     [Google Scholar]
  12. BermanD.P. McElhinneyD.B. VincentJ.A. HellenbrandW.E. ZahnE.M. Feasibility and short-term outcomes of percutaneous transcatheter pulmonary valve replacement in small (<30 kg) children with dysfunctional right ventricular outflow tract conduits.Circ. Cardiovasc. Interv.20147214214810.1161/CIRCINTERVENTIONS.113.000881 24569596
     [Google Scholar]
  13. AbdelghaniM. NassifM. BlomN.A. Infective endocarditis after melody valve implantation in the pulmonary position: A systematic review.J. Am. Heart Assoc.2018713e00816310.1161/JAHA.117.008163
     [Google Scholar]
  14. SlouhaE. JohnsonL.L. ThirunavukarasuA. Al-GeiziH. ClunesL.A. KolliasT.F. Risk of infective endocarditis post-transcatheter pulmonary valve replacement versus surgical pulmonary valve replacement: A systematic review.Cureus20231510e4802210.7759/cureus.48022
     [Google Scholar]
  15. GeorgievS. EwertP. EickenA. Munich comparative study: Prospective long-term outcome of the transcatheter Melody valve versus surgical pulmonary bioprosthesis with up to 12 Years of Follow-up.Circ. Cardiovasc. Interv.2020137e00896310.1161/CIRCINTERVENTIONS.119.008963 32600110
     [Google Scholar]
  16. Machanahalli BalakrishnaA. DilsaverD.B. AboeataA. Infective endocarditis risk with melody versus sapien valves following transcatheter pulmonary valve implantation: A systematic review and meta-analysis of prospective cohort studies.J. Clin. Med.20231215488610.3390/jcm12154886
     [Google Scholar]
/content/journals/ccr/10.2174/011573403X324878240903045701
Loading
Incidence of Infective Endocarditis Post-TPVR with MELODY Valve in Pediatric Patients: A Systematic Review and Meta-Analysis
Curr. Cardiol. Rev. 21, E1573403X324878 (2025); https://doi.org/10.2174/011573403X324878240903045701
/content/journals/ccr/10.2174/011573403X324878240903045701
/content/journals/ccr/10.2174/011573403X324878240903045701
Loading

Data & Media loading...

Supplements

Supplementary material is available on the publisher's website along with the published article.

file format download Download

  • Article Type:     Research Article
Keyword(s): COVID-19; heart failure; infective endocarditis; MELODY valve; pediatric population; TPVR

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test